Stockreport

Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Results

Eagle Pharmaceuticals, Inc.  (EGRX) 
Last eagle pharmaceuticals, inc. earnings: 3/2 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: investor.eagleus.com
PDF -- Q4 2019 net income was $0.07 per basic and diluted share and adjusted non-GAAP net income was $0.49 per basic and $0.48 per diluted share –-- FY 2019 net income was $ [Read more]